Pasniazid Tablets

The main ingredients are chemical combinations of isoniazid and para-aminosalicylic acid. When taken orally, it enters the body and is absorbed into the blood, releasing isoniazid and para-aminosalicylic acid, but it does not cause high concentrations of the active ingredients in the blood and tissues. It can easily pass through the blood-brain barrier. The tolerance of oral Lipaiji is better than that of isoniazid alone or isoniazid combined with para-aminosalicylic acid. Lipaiji is suitable for non-recumbent patients and various tuberculosis, as well as the combination of primary and secondary anti-tuberculosis drugs as any form of comprehensive treatment.

Lipahuiji is a light yellow tablet.

It is suitable for various pulmonary tuberculosis and other tuberculosis in adults and children treated with oral tuberculosis inhibitors: pulmonary tuberculosis, tuberculous encephalitis, respiratory tuberculosis, digestive tract tuberculosis, bone tuberculosis, urogenital tuberculosis. It is suitable for protection during surgical operations, especially in combination with other tuberculosis inhibitors (streptomycin); it is suitable for preventing relapse and continuing treatment.

Lipaiji should be taken orally after meals. Adults: Take 20-40 mg per kg of body weight per day, equivalent to 2-4 tablets per 10 kg of body weight. Children: Take 10-20 mg per kg of body weight per day, equivalent to 1-2 tablets per 10 kg of body weight. The daily dose should be taken in three to four times. The last dose should be taken between 8 and 9 pm to maintain the concentration of Lipaiji in the blood until the next morning. The maximum daily dose should not exceed 800 mg. Treatment course: The treatment course should be 6-10 months, and should not be shorter than 6 months.

No serious adverse reactions or intolerance were observed.

Keep away from light, sealed and stored in a dry place.

100 mg

36 months